Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1tirzepatidesafetyobesitycase-report

Case report links tirzepatide use to duodenal ulcer perforation

Cureus describes a patient who developed a perforated duodenal ulcer after tirzepatide injections for weight loss.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 17 07:09 ETSource: Cureus

The wire

  1. 01A single case report documents duodenal ulcer perforation following tirzepatide injections.
  2. 02Adds to safety case literature on GI events with incretin therapy.
  3. 03Causality cannot be established from one case.

From the source

Duodenal Ulcer Perforation Following Tirzepatide Injections for Weight Loss Management: A Case Report

Read at news.google.com